Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Alexander

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
The Oncologist|November 25, 2004
The past decade of experience with isolated hepatic perfusionAmelia Grover, H Richard Alexander
Surgical Oncology Clinics of North America|August 30, 2008
Development of isolated hepatic perfusion for patients who have unresectable hepatic malignanciesAdriana Jones, H Richard Alexander
Cancer Journal (Sudbury, Mass.)|May 15, 2002
Isolation perfusion of the liverNancy M Carroll, H Richard Alexander
Seminars in Oncology|April 16, 2002
Transarterial perfusion of liver metastasesDavid M Weinreich, H Richard Alexander
Pharmacology, Biochemistry, and Behavior|July 31, 2007
Operant leverpressing and wheelrunning were differentially reduced by PAPP (p-aminopropiophenone)-induced methemoglobinemiaRichard Alexander Bauman, John J Widholm
Surgical Oncology Clinics of North America|June 25, 2018
Peritoneal Metastases from Malignant MesotheliomaClaire Yue Li, H Richard Alexander
The American Journal of Medicine|April 3, 2007
Porcelain gallbladder and cancer: ethnicity explains a discrepant literature?Steven C Cunningham, H Richard Alexander
Cancer Journal (Sudbury, Mass.)|April 21, 2010
Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastasesH Richard Alexander, Caroline C Butler
Journal of Gastrointestinal Oncology|March 5, 2016
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancyGiorgos C Karakousis, H Richard Alexander
Journal of Gastrointestinal Oncology|March 5, 2016
Diagnosis and management of patients with malignant peritoneal mesotheliomaH Richard Alexander, Allen P Burke
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
The Oncologist|November 25, 2004
The past decade of experience with isolated hepatic perfusionAmelia Grover, H Richard Alexander
Surgical Oncology Clinics of North America|August 30, 2008
Development of isolated hepatic perfusion for patients who have unresectable hepatic malignanciesAdriana Jones, H Richard Alexander
Cancer Journal (Sudbury, Mass.)|May 15, 2002
Isolation perfusion of the liverNancy M Carroll, H Richard Alexander
Seminars in Oncology|April 16, 2002
Transarterial perfusion of liver metastasesDavid M Weinreich, H Richard Alexander
Pharmacology, Biochemistry, and Behavior|July 31, 2007
Operant leverpressing and wheelrunning were differentially reduced by PAPP (p-aminopropiophenone)-induced methemoglobinemiaRichard Alexander Bauman, John J Widholm
Surgical Oncology Clinics of North America|June 25, 2018
Peritoneal Metastases from Malignant MesotheliomaClaire Yue Li, H Richard Alexander
The American Journal of Medicine|April 3, 2007
Porcelain gallbladder and cancer: ethnicity explains a discrepant literature?Steven C Cunningham, H Richard Alexander
Cancer Journal (Sudbury, Mass.)|April 21, 2010
Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastasesH Richard Alexander, Caroline C Butler
Journal of Gastrointestinal Oncology|March 5, 2016
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancyGiorgos C Karakousis, H Richard Alexander
Journal of Gastrointestinal Oncology|March 5, 2016
Diagnosis and management of patients with malignant peritoneal mesotheliomaH Richard Alexander, Allen P Burke
Pageof 27